Jennifer J. Rhodes
2023
In 2023, Jennifer J. Rhodes earned a total compensation of $1.4M as former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary at Elicio Therapeutics, a 77% increase compared to previous year.
Compensation breakdown
| Bonus | $440,840 |
|---|---|
| Salary | $222,257 |
| Other | $702,762 |
| Total | $1,365,859 |
Rhodes received $702.8K in other compensation, accounting for 51% of the total pay in 2023.
Rhodes also received $440.8K in bonus and $222.3K in salary.
Rankings
In 2023, Jennifer J. Rhodes' compensation ranked 874th out of 2,983 executives tracked by ExecPay. In other words, Rhodes earned more than 70.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 874 out of 2,983 | 71st |
Division Manufacturing | 511 out of 1,637 | 69th |
Major group Chemicals And Allied Products | 348 out of 906 | 62nd |
Industry group Drugs | 338 out of 869 | 61st |
Industry Pharmaceutical Preparations | 229 out of 627 | 64th |
Source: SEC filing on September 27, 2024.
Rhodes' colleagues
We found four more compensation records of executives who worked with Jennifer J. Rhodes at Elicio Therapeutics in 2023.